China’s Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics Nguyen Thi Bich Ngoc September 19, 2017 PremiumChinese investment firm Wuxi Healthcare Ventures has led a $55-million series A financing for US-based biotech company LifeMine Therapeutics after earlier investing in its $5 million seed round. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Should your colleagues be reading this article too? Contact us for corporate subscriptions at email@example.com.